I

IDRx

16 employees

Idrx is a clinical-stage biopharmaceutical company dedicated to transforming cancer treatment.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Product Research
Life Science

Date founded

2022

Funding rounds raised

Total raised

$122M

from 3 investors over 3 rounds

I

IDRx raised $122M on August 2, 2022

Investors: Casdin Capital, LLC, Andreessen Horowitz and Nextech Invest

FAQ